Guillermo Uy, MD
Surgery · Middletown, NYNPI 1285773200
Payments from drug & device makers
What this record shows
This record is dominated by education: $190,000 of the $199,055 with a category attached, or 95.5%. Intuitive Surgical accounts for 99.6% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $68,497 and has fallen 61.6% since, to $26,326 in 2025. Among surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $829.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$198K
- Davol Inc.$604
- W. L. Gore & Associates, Inc.$122
- KARL Storz Endoscopy-america$27
- Baxter Healthcare$27
- Covidien LP$11
What the payments were for
- Travel & lodging$3,5512%
- Food & beverage$5,5053%
- Education$190,00095%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 220 | $198,264 |
| Davol Inc. | 16 | $604 |
| W. L. Gore & Associates, Inc. | 1 | $122 |
| KARL Storz Endoscopy-america | 1 | $27 |
| Baxter Healthcare | 1 | $27 |
| Covidien LP | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$199,055 in reported general payments places this provider in the 95th percentile of 1,596 surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 25 | $288 |
| Tramadol Hcl | 183 | $223 |
| Neomycin Sulfate | 43 | $207 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $184 |
| Metronidazole | 45 | $55 |
Paid to pharmacies, not to this prescriber.
Other surgery in Middletown
- Cheguevara AfanehNew York$1.4M
- Flavio Malcher Martins de OliveiraNew York$695K
- Yuri NovitskyNew York$548K
- Rasa ZarnegarNew York$478K
- Tanuja DamaniNew York$459K
- Benjamin SadowitzSyracuse$419K
- Stephen GoldstoneNy$386K
- Rache SimmonsNew York$371K
- George DenotoManhasset$333K
- Marina KurianNew York$328K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.